Spin-Offs
The skills and initiative of the University research groups generate new companies that bring to the market the applications of the latest scientific and technological breakthroughs. The University of Milan encourages the participation of national and international third parties that can provide spin-offs with the tools to grow and thrive on the market.
The Unimi Foundation helps these companies to establish themselves on the market and identify potential industrial partners.
Contact details
For more information on how to collaborate with and invest in the University's Spin-Offs: [email protected]
Moovet delivers advanced miRNA diagnostic lab services to every veterinarian. Its unique platform enables early, accurate disease detection—improving outcomes and animal welfare like never before.
Academic Spin-off born to turn the most recent discoveries in the genetics and molecular biology fields into innovative rice varieties, apt to rice cultivation challenges of today and of the future.
ADD srl is an innovative start-up aiming to develop ColOrPlat, an advanced technology for targeted drug release in the proximal colon. ADD seeks to expand its portfolio of oral delivery platforms over time, addressing the needs of the pharmaceutical and biotechnology industries.
Glutensens wants to introduce a device to the market for the rapid measurement of gluten in catering food, with the aim of protecting people that suffer from celiac disease or gluten-related disorders.
PepTiDa is a leader in the research and development of peptide and peptidomimetic molecules for the treatment of severe diseases, with a particular focus on neurodegeneration.
VisioNing develops a product that combines innovative technologies to not only purify water, but also recover and reuse the nutrients it contains, reducing the consumption of water resources and raw materials in a circular economy perspective.
Plantech is a Spin-Off which creates innovative peptide ingredients and nano-vesicles thanks to patented processes that integrate biotechnology and nanotechnology and which is aimed at the cosmetic, nutraceutical and biomedical sectors.
The company develops digital ecosystems for the verification, control and supervision of systems based on the integration of data-driven technologies and machine learning, with particular reference to the analysis of issues of fairness, bias and transparency.
The EEM Team Spin-off Company mission is developing and commercializing a software able to visualize and analyze geophysical, geological and hydrogeological data and offering consulting services in terms of geophysical data acquisition, elaboration and interpretation.
The mission at Nephris is to develop first-in-class therapies for chronic kidney disease in diabetic patients (also known as Diabetic Nephropathy/Diabetic Kidney Disease, DKD). Nephris’ research activities are focused on novel targets of glomerular damage in DKD to develop novel therapeutic strategies aiming at preventing, halting or reversing DKD.
Huvant produces virtual and tactile models of complex organs for human surgery. The models let surgery students, interns and surgeons practice allowing the development of less invasive and more precise specific procedures for the patient.
Viridis’ proposal is offering innovative technologies to improve the effectiveness of waste and by-product valorization processes, starting off from the diary and agro-industrial sectors.
The Spin-off aims at realizing and offering to the Italian agribusiness market a voluntary label that can be paired to the obligatory one issued by the European Commission and that is based on a sustainability index of the product and the production chain.
The main objective of Intrinsic Powers Inc. is to optimize, certify and commercialize a practical and reliable tool that makes it possible to detect consciousness and its recovery during medical practice.
Technological platform with digital services for the capture and valorisation of CO₂ in the agricultural sector.
Spin-Off specializing in regenerative medicine for neurological diseases. It has developed a revolutionary cell therapy for the regeneration of damaged nervous tissues, which finds application in the healing of spinal cord injuries in the sub-acute phase.
Creation of a technological platform where to develop technologies with high innovative value, intended mainly, but not exclusively, for the flexible-packaging sector.
Spin-Off specializzata in soluzioni tecnologiche per la gestione sostenibile delle risorse idriche e la difesa del territorio.
Sviluppo di soluzioni digitali per il settore agroambientale: agricoltura di precisione, ideotyping, assicurazioni parametriche.
Realizza sistemi innovativi di diagnostica precoce facilmente installabili per monitorare lo stato di salute degli animali attraverso l’analisi delle loro emissioni odorose.
Authclick deals with the protection of rights and transparency in transactions, enhancement, certification, archiving and digitization of photography.
Innovazione tecnologica e organizzativa per la gestione e il recupero degli scarti e delle eccedenze alimentari nella ristorazione.
Piattaforma B2B innovativa completamente configurabile dall’utente finale che verifica e monitora di continuo la conformità dei sistemi ICT alle politiche di sicurezza.
It provides data analysis and visualization services based on advanced algorithms developed in the field of complex systems research.
Sviluppo di nuove terapie contro il cancro e le malattie autoimmuni, nuovi strumenti terapeutici per produrre anticorpi monoclonali.
Produce capsule di integratori personalizzate sia nel contenuto (dose e combinazione delle singole molecole) sia nei tempi di rilascio.
It provides innovative therapeutic tools, information systems and services for neuromodulation.